Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)

Clinical trial NCT06809764 · RECRUITING

Trial details

NCT number: NCT06809764
Sponsor: Daiichi Sankyo
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2025-02-21
Primary completion: 2027-02-12
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.